NIVF vs PIII

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

NIVF

33.1
AI Score
VS
PIII Wins

PIII

61.3
AI Score

Investment Advisor Scores

NIVF

33score
Recommendation
EXTENDED

PIII

61score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NIVF PIII Winner
Forward P/E 0.0139 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 11.9% 8.6% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 33.1/100 61.3/100 PIII
Profit Margin 209.0% -6.6% NIVF
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

NIVF 1M: +102.4% · 3M: +84.3% PIII 1M: -27.9% · 3M: -37.8%

Current Technical Phase

NIVF

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.3% over 20 days), RSI 60

RSI (14): 59.7 · Price: $1.06

PIII

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 35

RSI (14): 35.4 · Price: $8.43

Fundamentals Snapshot

Metric NIVF PIII
Market Cap
Forward P/E 0.0 -0.6
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.0%
Operating Margin -3.5% 0.1%
EPS 328.32 -32.47
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PIII is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.